Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,195.65
+52.05 (2.43%)
At close: Apr 21, 2026
Mankind Pharma Revenue
Mankind Pharma had revenue of 35.67B INR in the quarter ending December 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 139.14B, up 19.53% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.
Revenue (ttm)
139.14B
Revenue Growth
+19.53%
P/S Ratio
6.53
Revenue / Employee
7.09M
Employees
19,620
Market Cap
908.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 122.07B | 19.47B | 18.98% |
| Mar 31, 2024 | 102.60B | 15.11B | 17.27% |
| Mar 31, 2023 | 87.49B | 9.68B | 12.44% |
| Mar 31, 2022 | 77.82B | 15.67B | 25.22% |
| Mar 31, 2021 | 62.14B | 3.43B | 5.83% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Torrent Pharmaceuticals | 127.42B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |